Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Growth Regulatory News (ALGW)

  • There is currently no data for ALGW

Shareholder Update Call

27 Mar 2025 07:00

RNS Number : 4161C
Alpha Growth PLC
27 March 2025
 

 

 

REACH: non-regulatory announcement

Alpha Growth plc

("Alpha" or the "Company")

Shareholder Update Call

Alpha Growth Plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services company in the life insurance linked asset/wealth management business, announces that their leadership team will host a live interactive call on the Engage Investor platform, on the 2nd of April 2025, at 11:00am BST. 

Alpha Growth Plc welcomes all current shareholders to join and encourages shareholders to pre-submit questions. Investors can also submit questions at any time during the live presentation. 

Investors can sign up to Engage Investor at no cost and follow Alpha Growth Plc from their personalised investor hub.

Register interest in this event here: https://engageinvestor.news/alpha_IP25

 

Alpha Growth plc

+44 (0) 20 3959 8600

Gobind Sahney, Executive Chairman

info@algwplc.com

 

Allenby Capital Limited

+44 (0) 20 3328 5656

Amrit Nahal (Sales and Corporate Broking)

Nick Athanas / Piers Shimwell (Corporate Finance)

 

UK Investor Relations - Mark Treharne

ir@algwplc.com

 

 

About Alpha Growth plc

 

Specialist in Longevity Assets

 

Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets and insurance linked asset and wealth management. Building on its well-established network, the Alpha Growth group has a unique position in the insurance and asset services and investment business, as a listed entity with global reach. The group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

 

Longevity Assets and Non-correlation

 

As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets. Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.

 

Note: The Company only advises on and manages Longevity Assets that originate in the USA where the structured and life settlement market is highly regulated.

 

***END***

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAEDXAEASEEA
Date   Source Headline
28th Sep 20227:00 amRNSAppointment as Investment Manager/Insurance Update
12th Sep 20222:06 pmRNSSecond Price Monitoring Extn
12th Sep 20222:00 pmRNSPrice Monitoring Extension
9th Sep 20222:06 pmRNSSecond Price Monitoring Extn
9th Sep 20222:00 pmRNSPrice Monitoring Extension
8th Sep 20227:00 amRNSDirector and Personnel Announcement
3rd Aug 20227:00 amRNSHolding(s) in Company
26th Jul 20224:40 pmRNSSecond Price Monitoring Extn
26th Jul 20224:35 pmRNSPrice Monitoring Extension
20th Jun 20224:03 pmRNSResults of the Annual General Meeting
31st May 20227:00 amRNSRelease of 2021 Annual Report
27th Apr 20227:00 amRNSShareholder Information Update
24th Mar 20224:41 pmRNSSecond Price Monitoring Extn
24th Mar 20224:36 pmRNSPrice Monitoring Extension
24th Mar 20222:05 pmRNSSecond Price Monitoring Extn
24th Mar 20222:00 pmRNSPrice Monitoring Extension
24th Mar 20227:00 amRNSAcquisition and Insurance Business Update
7th Mar 20224:41 pmRNSSecond Price Monitoring Extn
7th Mar 20224:35 pmRNSPrice Monitoring Extension
7th Mar 20222:05 pmRNSSecond Price Monitoring Extn
7th Mar 20222:00 pmRNSPrice Monitoring Extension
7th Mar 202211:06 amRNSSecond Price Monitoring Extn
7th Mar 202211:00 amRNSPrice Monitoring Extension
28th Feb 20227:00 amRNSBusiness Update - 2022 Focus and the 2B Plan
21st Feb 20227:00 amRNSAppointment of new Strategic Advisor
2nd Feb 20227:00 amRNSBlackOak Alpha Growth Fund 2021 Year End Results
20th Dec 20217:00 amRNSPublication of a Prospectus
17th Dec 20217:00 amRNSChange of Adviser
13th Dec 20216:14 pmRNSHolding(s) in Company
29th Oct 202112:00 pmRNSInterim Results for Extension in Accounting Period
2nd Sep 20214:41 pmRNSSecond Price Monitoring Extn
2nd Sep 20214:35 pmRNSPrice Monitoring Extension
12th Aug 20214:40 pmRNSSecond Price Monitoring Extn
12th Aug 20214:35 pmRNSPrice Monitoring Extension
19th Jul 20214:40 pmRNSSecond Price Monitoring Extn
19th Jul 20214:35 pmRNSPrice Monitoring Extension
19th Jul 20217:00 amRNSTrading Update Q2 2021
6th Jul 20218:00 amRNSChange of Year End
16th Jun 20217:00 amRNSClarification of News
15th Jun 202111:05 amRNSSecond Price Monitoring Extn
15th Jun 202111:00 amRNSPrice Monitoring Extension
15th Jun 20219:05 amRNSSecond Price Monitoring Extn
15th Jun 20219:00 amRNSPrice Monitoring Extension
7th Jun 20217:00 amRNSHolding(s) in Company
7th Jun 20217:00 amRNSWarrants Exercise and Admission Date
2nd Jun 20217:00 amRNSHolding(s) in Company
28th May 20214:00 pmRNSInterim Results
19th May 20217:00 amRNSExercise of Warrants and Total Voting Rights
14th May 20217:00 amRNSHolding(s) in Company
13th May 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.